Holly Rockweiler is co-founder and CEO of Madorra, a women’s health company dedicated to changing the treatment paradigm for vaginal dryness.

Rockweiler co-founded Madorra three years ago as a spin-out of the Stanford Biodesign Fellowship. Prior to Biodesign, she worked as a senior research scientist in the Cardiac Rhythm Management division of Boston Scientific. There, she co-developed a new sensing algorithm for cardiac resynchronization therapy that enables more efficient care for patients living with heart failure. Her work has led to 15 pending and issued patents. Rockweiler holds a Master of Science and a Bachelor of Science in biomedical engineering from Washington University in St. Louis.